26
|
Kannangara DRW, Phipps-Green AJ, Dalbeth N, Stamp LK, Williams KM, Graham GG, Day RO, Merriman TR. Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Ann Rheum Dis 2015; 75:1363-6. [PMID: 26835700 DOI: 10.1136/annrheumdis-2015-208111] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2015] [Accepted: 11/07/2015] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To investigate the contributions towards hyperuricaemia of known risk factors, focusing on fractional (renal) clearance of urate (FCU) and variation in the ATP-binding cassette transporter, sub-family G 2 (ABCG2) gene. METHODS The contributions of age, sex, ancestry, Q141K genotype for ABCG2, FCU, sugar-sweetened beverage and alcohol consumption, metabolic syndrome disorders and measures of renal function to the risk of hyperuricaemia were evaluated by comparing hyperuricaemic (serum urate≥0.42 mmol/L, n=448) with normouricaemic (serum urate<0.42 mmol/L, n=344) participants using stepwise logistic regression. Model performance was evaluated using the area under the receiver operator characteristic curve (AUROC). RESULTS ABCG2 genotype, FCU, male sex, body mass index, serum triglyceride concentrations, estimated glomerular filtration rate and consumption of alcohol were the best predictors of hyperuricaemia (AUROC 0.90, 81% accuracy). Homozygosity in the 141K variant for ABCG2 conferred an adjusted OR of 10.5 for hyperuricaemia (95% CI 2.4 to 46.2). For each 1% decrease of FCU, the adjusted OR increased by 51% (OR 1.51, 95% CI 1.37 to 1.66). There was no association between ABCG2 genotype and FCU (r=0.02, p=0.83). CONCLUSIONS The ABCG2 141K variant and the FCU contribute strongly but independently to hyperuricaemia. These findings provide further evidence for a significant contribution of ABCG2 to extra-renal (gut) clearance of urate.
Collapse
|
27
|
Chang YY, Wang MZ, Abdesselam A, Adachi I, Adamczyk K, Aihara H, Al Said S, Asner DM, Atmacan H, Aushev T, Babu V, Badhrees I, Bakich AM, Barberio E, Bhuyan B, Biswal J, Bobrov A, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Danilov M, Dingfelder J, Doležal Z, Drásal Z, Dutta D, Eidelman S, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Ganguly S, Garmash A, Gillard R, Glattauer R, Goh YM, Goldenzweig P, Greenwald D, Grzymkowska O, Haba J, Hayasaka K, Hayashii H, He XH, Hou WS, Hsu CL, Iijima T, Inami K, Ishikawa A, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Joffe D, Joo KK, Kawasaki T, Kim DY, Kim HJ, Kim JB, Kim JH, Kim KT, Kim MJ, Kim SH, Kim YJ, Kinoshita K, Korpar S, Križan P, Krokovny P, Kuhr T, Kumita T, Kuzmin A, Kwon YJ, Lai YT, Lee IS, Li L, Li Y, Libby J, Liventsev D, Lukin P, Masuda M, Matvienko D, Miyabayashi K, Miyake H, Miyata H, Mizuk R, Mohanty GB, Mohanty S, Moll A, Moon HK, Mori T, Nakano E, Nakao M, Nanut T, Nayak M, Nishida S, Ogawa S, Ozaki H, Pakhlov P, Pakhlova G, Pal B, Park CW, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Rauch J, Ribežl E, Ritter M, Rostomyan A, Ryu S, Sahoo H, Sakai Y, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Seong IS, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simon F, Sohn YS, Starič M, Stypula J, Sumihama M, Sumisawa K, Sumiyoshi T, Tamponi U, Tanida K, Teramoto Y, Uglov T, Unno Y, Uno S, Usov Y, Van Hulse C, Vanhoefer P, Varner G, Vorobyev V, Vossen A, Wagner MN, Wang CH, Wang P, Watanabe M, Watanabe Y, Williams KM, Won E, Yamaoka J, Yashchenko S, Yelton J, Yusa Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Observation of B^{0}→pΛ[over ¯]D^{(*)-}. PHYSICAL REVIEW LETTERS 2015; 115:221803. [PMID: 26650291 DOI: 10.1103/physrevlett.115.221803] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2015] [Indexed: 06/05/2023]
Abstract
We report the first observation of the decays B^{0}→pΛ[over ¯]D^{(*)-}. The data sample of 711 fb^{-1} used in this analysis corresponds to 772×10^{6} BB[over ¯] pairs, collected at the ϒ(4S) resonance by the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. We observe 19.8σ and 10.8σ excesses of events for the two decay modes and measure the branching fractions of B^{0}→pΛ[over ¯]D^{-} and B^{0}→pΛ[over ¯]D^{*-} to be (25.1±2.6±3.5)×10^{-6} and (33.6±6.3±4.4)×10^{-6}, respectively, where the first uncertainties are statistical and the second are systematic. These results are not compatible with the predictions based on the generalized factorization approach. In addition, a threshold enhancement in the dibaryon (pΛ[over ¯]) system is observed, consistent with that observed in similar B decays.
Collapse
|
28
|
Vaccher S, Kannangara DRW, Baysari MT, Reath J, Zwar N, Williams KM, Day RO. Barriers to Care in Gout: From Prescriber to Patient. J Rheumatol 2015; 43:144-9. [PMID: 26568590 DOI: 10.3899/jrheum.150607] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/17/2015] [Indexed: 01/24/2023]
Abstract
OBJECTIVE To explore the understanding of gout and its management by patients and general practitioners (GP), and to identify barriers to optimal gout care. METHODS Semistructured interviews were conducted with 15 GP and 22 patients in Sydney, Australia. Discussions were focused on medication adherence, experiences with gout, and education and perceptions around interventions for gout. Interviews were audio recorded, transcribed verbatim, and analyzed for themes using an analytical framework. RESULTS Adherence to urate-lowering medications was identified as problematic by GP, but less so by patients with gout. However, patients had little appreciation of the risk of acute attacks related to variable adherence. Patients felt stigmatized that their gout diagnosis was predominantly related to perceptions that alcohol and dietary excess were causal. Patients felt they did not have enough education about gout and how to manage it. A manifestation of this was that uric acid concentrations were infrequently measured. GP were concerned that they did not know enough about managing gout and most were not familiar with current guidelines for management. For example and importantly, the strategies for reducing the risk of acute attacks when commencing urate-lowering therapy (ULT) were not well appreciated by GP or patients. CONCLUSION Patients and GP wished to know more about gout and its management. Greater success in establishing and maintaining ULT will require further and better education to substantially benefit patients. Also, given the prevalence, and personal and societal significance of gout, innovative approaches to transforming the management of this eminently treatable disease are needed.
Collapse
|
29
|
McKinney C, Stamp LK, Dalbeth N, Topless RK, Day RO, Kannangara DR, Williams KM, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, So A, Merriman TR. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Res Ther 2015; 17:288. [PMID: 26462562 PMCID: PMC4604627 DOI: 10.1186/s13075-015-0802-3] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2015] [Accepted: 09/26/2015] [Indexed: 02/07/2023] Open
Abstract
Introduction The acute gout flare results from a localised self-limiting innate immune response to monosodium urate (MSU) crystals deposited in joints in hyperuricaemic individuals. Activation of the caspase recruitment domain-containing protein 8 (CARD8) NOD-like receptor pyrin-containing 3 (NLRP3) inflammasome by MSU crystals and production of mature interleukin-1β (IL-1β) is central to acute gouty arthritis. However very little is known about genetic control of the innate immune response involved in acute gouty arthritis. Therefore our aim was to test functional single nucleotide polymorphism (SNP) variants in the toll-like receptor (TLR)-inflammasome-IL-1β axis for association with gout. Methods 1,494 gout cases of European and 863 gout cases of New Zealand (NZ) Polynesian (Māori and Pacific Island) ancestry were included. Gout was diagnosed by the 1977 ARA gout classification criteria. There were 1,030 Polynesian controls and 10,942 European controls including from the publicly-available Atherosclerosis Risk in Communities (ARIC) and Framingham Heart (FHS) studies. The ten SNPs were either genotyped by Sequenom MassArray or by Affymetrix SNP array or imputed in the ARIC and FHS datasets. Allelic association was done by logistic regression adjusting by age and sex with European and Polynesian data combined by meta-analysis. Sample sets were pooled for multiplicative interaction analysis, which was also adjusted by sample set. Results Eleven SNPs were tested in the TLR2, CD14, IL1B, CARD8, NLRP3, MYD88, P2RX7, DAPK1 and TNXIP genes. Nominally significant (P < 0.05) associations with gout were detected at CARD8 rs2043211 (OR = 1.12, P = 0.007), IL1B rs1143623 (OR = 1.10, P = 0.020) and CD14 rs2569190 (OR = 1.08; P = 0.036). There was significant multiplicative interaction between CARD8 and IL1B (P = 0.005), with the IL1B risk genotype amplifying the risk effect of CARD8. Conclusion There is evidence for association of gout with functional variants in CARD8, IL1B and CD14. The gout-associated allele of IL1B increases expression of IL-1β – the multiplicative interaction with CARD8 would be consistent with a synergy of greater inflammasome activity (resulting from reduced CARD8) combined with higher levels of pre-IL-1β expression leading to increased production of mature IL-1β in gout. Electronic supplementary material The online version of this article (doi:10.1186/s13075-015-0802-3) contains supplementary material, which is available to authorized users.
Collapse
|
30
|
Tamponi U, Mussa R, Abdesselam A, Aihara H, Arinstein K, Asner DM, Atmacan H, Aushev T, Ayad R, Badhrees I, Bakich AM, Barberio E, Bhardwaj V, Bhuyan B, Biswal J, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chen A, Cheon BG, Cho K, Chobanova V, Choi SK, Choi Y, Cinabro D, Danilov M, Doležal Z, Drásal Z, Drutskoy A, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Getzkow D, Gillard R, Goh YM, Golob B, Haba J, Hayasaka K, Hayashii H, He XH, Hedges MT, Hou WS, Iijima T, Inami K, Ishikawa A, Jaegle I, Joffe D, Julius T, Kato E, Katrenko P, Kichimi H, Kiesling C, Kim DY, Kim HJ, Kim JH, Kim KT, Kim SH, Kinoshita K, Kodyš P, Korpar S, Križan P, Krokovny P, Kumita T, Kuzmin A, Lange JS, Lewis P, Libby J, Lukin P, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Mori T, Nakano E, Nakao M, Nanut T, Natkaniec Z, Nayak M, Nisar NK, Nishida S, Ogawa S, Okuno S, Olsen SL, Ostrowicz W, Oswald C, Pakhlova G, Pal B, Park H, Pedlar TK, Pesántez L, Pestotnik R, Petrič M, Piilonen LE, Ribežl E, Ritter M, Rostomyan A, Ryu S, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schneider O, Schnell G, Schwanda C, Semmler D, Senyo K, Sevior ME, Shapkin M, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sohn YS, Sokolov A, Starič M, Steder M, Stypula J, Tanida K, Teramoto Y, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Van Hulse C, Vanhoefer P, Varner G, Vinokurova A, Vossen A, Wagner MN, Wang MZ, Wang XL, Watanabe Y, Williams KM, Won E, Yamaoka J, Yashchenko S, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. First Observation of the Hadronic Transition ϒ(4S)→ηh(b)(1P) and New Measurement of the h(b)(1P) and η(b)(1S) Parameters. PHYSICAL REVIEW LETTERS 2015; 115:142001. [PMID: 26551806 DOI: 10.1103/physrevlett.115.142001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2015] [Indexed: 06/05/2023]
Abstract
Using a sample of 771.6×10(6) ϒϒ(4S) decays collected by the Belle experiment at the KEKB e(+)e(-) collider, we observe, for the first time, the transition ϒ(4S)→ηh(b)(1P) with the branching fraction B[ϒ(4S)→ηh(b)(1P)]=(2.18±0.11±0.18)×10(-3) and we measure the h(b)(1P) mass M(h(b)(1P))=(9899.3±0.4±1.0) MeV/c(2), corresponding to the hyperfine (HF) splitting ΔM(HF)(1P)=(0.6±0.4±1.0) MeV/c(2). Using the transition h(b)(1P)→γη(b)(1S), we measure the η(b)(1S) mass M(η(b)(1S))=(9400.7±1.7±1.6) MeV/c(2), corresponding to ΔM(HF)(1S)=(59.6±1.7±1.6) MeV/c(2), the η(b)(1S) width Γ(η(b)(1S))=(8(-5)(+6)±5) MeV/c(2) and the branching fraction B[h(b)(1P)→γη(b)(1S)]=(56±8±4)%.
Collapse
|
31
|
Abdesselam A, Adachi I, Adametz A, Adye T, Ahmed H, Aihara H, Akar S, Alam MS, Albert J, Al Said S, Andreassen R, Angelini C, Anulli F, Arinstein K, Arnaud N, Asner DM, Aston D, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Band HR, Banerjee S, Barberio E, Bard DJ, Barlow RJ, Batignani G, Beaulieu A, Bellis M, Ben-Haim E, Bernard D, Bernlochner FU, Bettarini S, Bettoni D, Bevan AJ, Bhardwaj V, Bhuyan B, Bianchi F, Biasini M, Biswal J, Blinov VE, Bloom PC, Bobrov A, Bomben M, Bondar A, Bonneaud GR, Bonvicini G, Bozek A, Bozzi C, Bračko M, Briand H, Browder TE, Brown DN, Brown DN, Bünger C, Burchat PR, Buzykaev AR, Calabrese R, Calcaterra A, Calderini G, Carpinelli M, Cartaro C, Casarosa G, Cenci R, Červenkov D, Chang P, Chao DS, Chauveau J, Cheaib R, Chekelian V, Chen A, Chen C, Cheng CH, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi HHF, Choi SK, Chrzaszcz M, Cibinetto G, Cinabro D, Cochran J, Coleman JP, Contri R, Convery MR, Cowan G, Cowan R, Cremaldi L, Dalseno J, Dasu S, Davier M, Davis CL, De Mori F, De Nardo G, Denig AG, Derkach D, de Sangro R, Dey B, Di Lodovico F, Dingfelder J, Dittrich S, Doležal Z, Dorfan J, Drásal Z, Drutskoy A, Druzhinin VP, Dubois-Felsmann GP, Dunwoodie W, Dutta D, Ebert M, Echenard B, Eidelman S, Eigen G, Eisner AM, Emery S, Ernst JA, Faccini R, Farhat H, Fast JE, Feindt M, Ferber T, Ferrarotto F, Ferroni F, Field RC, Filippi A, Finocchiaro G, Fioravanti E, Flood KT, Ford WT, Forti F, Franco Sevilla M, Fritsch M, Fry JR, Fulsom BG, Gabathuler E, Gabyshev N, Gamba D, Garmash A, Gary JW, Garzia I, Gaspero M, Gaur V, Gaz A, Gershon TJ, Getzkow D, Gillard R, Li Gioi L, Giorgi MA, Glattauer R, Godang R, Goh YM, Goldenzweig P, Golob B, Golubev VB, Gorodeisky R, Gradl W, Graham MT, Grauges E, Griessinger K, Gritsan AV, Grosdidier G, Grünberg O, Guttman N, Haba J, Hafner A, Hamilton B, Hara T, Harrison PF, Hast C, Hayasaka K, Hayashii H, Hearty C, He XH, Hess M, Hitlin DG, Hong TM, Honscheid K, Hou WS, Hsiung YB, Huard Z, Hutchcroft DE, Iijima T, Inguglia G, Innes WR, Ishikawa A, Itoh R, Iwasaki Y, Izen JM, Jaegle I, Jawahery A, Jessop CP, Joffe D, Joo KK, Julius T, Kang KH, Kass R, Kawasaki T, Kerth LT, Khan A, Kiesling C, Kim DY, Kim JB, Kim JH, Kim KT, Kim P, Kim SH, Kim YJ, King GJ, Kinoshita K, Ko BR, Koch H, Kodyš P, Kolomensky YG, Korpar S, Kovalskyi D, Kowalewski R, Kravchenko EA, Križan P, Krokovny P, Kuhr T, Kumar R, Kuzmin A, Kwon YJ, Lacker HM, Lafferty GD, Lanceri L, Lange DJ, Lankford AJ, Latham TE, Leddig T, Le Diberder F, Lee DH, Lee IS, Lee MJ, Lees JP, Leith DWGS, Leruste P, Lewczuk MJ, Lewis P, Libby J, Lockman WS, Long O, Lopes Pegna D, LoSecco JM, Lou XC, Lueck T, Luitz S, Lukin P, Luppi E, Lusiani A, Luth V, Lutz AM, Lynch G, MacFarlane DB, Malaescu B, Mallik U, Manoni E, Marchiori G, Margoni M, Martellotti S, Martinez-Vidal F, Masuda M, Mattison TS, Matvienko D, McKenna JA, Meadows BT, Miyabayashi K, Miyashita TS, Miyata H, Mizuk R, Mohanty GB, Moll A, Monge MR, Moon HK, Morandin M, Muller DR, Mussa R, Nakano E, Nakazawa H, Nakao M, Nanut T, Nayak M, Neal H, Neri N, Nisar NK, Nishida S, Nugent IM, Oberhof B, Ocariz J, Ogawa S, Okuno S, Olaiya EO, Olsen J, Ongmongkolkul P, Onorato G, Onuchin AP, Onuki Y, Ostrowicz W, Oyanguren A, Pakhlova G, Pakhlov P, Palano A, Pal B, Palombo F, Pan Y, Panduro Vazquez W, Paoloni E, Park CW, Park H, Passaggio S, Patel PM, Patrignani C, Patteri P, Payne DJ, Pedlar TK, Peimer DR, Peruzzi IM, Pesántez L, Pestotnik R, Petrič M, Piccolo M, Piemontese L, Piilonen LE, Pilloni A, Piredda G, Playfer S, Poireau V, Porter FC, Posocco M, Prasad V, Prell S, Prepost R, Puccio EMT, Pulliam T, Purohit MV, Pushpawela BG, Rama M, Randle-Conde A, Ratcliff BN, Raven G, Ribežl E, Richman JD, Ritchie JL, Rizzo G, Roberts DA, Robertson SH, Röhrken M, Roney JM, Roodman A, Rossi A, Rostomyan A, Rotondo M, Roudeau P, Sacco R, Sakai Y, Sandilya S, Santelj L, Santoro V, Sanuki T, Sato Y, Savinov V, Schindler RH, Schneider O, Schnell G, Schroeder T, Schubert KR, Schumm BA, Schwanda C, Schwartz AJ, Schwitters RF, Sciacca C, Seiden A, Sekula SJ, Senyo K, Seon O, Serednyakov SI, Sevior ME, Shapkin M, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simard M, Simi G, Simon F, Simonetto F, Skovpen YI, Smith AJS, Smith JG, Snyder A, So RY, Sobie RJ, Soffer A, Sohn YS, Sokoloff MD, Sokolov A, Solodov EP, Solovieva E, Spaan B, Spanier SM, Starič M, Stocchi A, Stroili R, Stugu B, Su D, Sullivan MK, Sumihama M, Sumisawa K, Sumiyoshi T, Summers DJ, Sun L, Tamponi U, Taras P, Tasneem N, Teramoto Y, Tisserand V, Todyshev KY, Toki WH, Touramanis C, Trabelsi K, Tsuboyama T, Uchida M, Uglov T, Unno Y, Uno S, Usov Y, Uwer U, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Vasseur G, Va'vra J, Verderi M, Vinokurova A, Vitale L, Vorobyev V, Voß C, Wagner MN, Wagner SR, Waldi R, Walsh JJ, Wang CH, Wang MZ, Wang P, Watanabe Y, West CA, Williams KM, Wilson FF, Wilson JR, Wisniewski WJ, Won E, Wormser G, Wright DM, Wu SL, Wulsin HW, Yamamoto H, Yamaoka J, Yashchenko S, Yuan CZ, Yusa Y, Zallo A, Zhang CC, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. First Observation of CP Violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} Decays by a Combined Time-Dependent Analysis of BABAR and Belle Data. PHYSICAL REVIEW LETTERS 2015; 115:121604. [PMID: 26430984 DOI: 10.1103/physrevlett.115.121604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Indexed: 06/05/2023]
Abstract
We report a measurement of the time-dependent CP asymmetry of B[over ¯]^{0}→D_{CP}^{(*)}h^{0} decays, where the light neutral hadron h^{0} is a π^{0}, η, or ω meson, and the neutral D meson is reconstructed in the CP eigenstates K^{+}K^{-}, K_{S}^{0}π^{0}, or K_{S}^{0}ω. The measurement is performed combining the final data samples collected at the ϒ(4S) resonance by the BABAR and Belle experiments at the asymmetric-energy B factories PEP-II at SLAC and KEKB at KEK, respectively. The data samples contain (471±3)×10^{6} BB[over ¯] pairs recorded by the BABAR detector and (772±11)×10^{6} BB[over ¯] pairs recorded by the Belle detector. We measure the CP asymmetry parameters -η_{f}S=+0.66±0.10(stat)±0.06(syst) and C=-0.02±0.07(stat)±0.03(syst). These results correspond to the first observation of CP violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} decays. The hypothesis of no mixing-induced CP violation is excluded in these decays at the level of 5.4 standard deviations.
Collapse
|
32
|
Jaegle I, Adachi I, Aihara H, Al Said S, Asner DM, Aushev T, Ayad R, Bakich AM, Bansal V, Barrett M, Bhuyan B, Bozek A, Bračko M, Browder TE, Červenkov D, Chang MC, Cheon BG, Chilikin K, Cho K, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Doležal Z, Drásal Z, Drutskoy A, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Frost O, Gaur V, Gabyshev N, Ganguly S, Garmash A, Getzkow D, Gillard R, Goh YM, Golob B, Grzymkowska O, Hayasaka K, Hayashii H, He XH, Hedges M, Hou WS, Iijima T, Inami K, Ishikawa A, Iwasaki Y, Julius T, Kang KH, Kato E, Kawasaki T, Kim DY, Kim JB, Kim JH, Kim SH, Kinoshita K, Ko BR, Kodyš P, Korpar S, Križan P, Krokovny P, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Lewis P, Li Gioi L, Libby J, Liventsev D, Matvienko D, Miyata H, Mizuk R, Mohanty GB, Moll A, Mussa R, Nakano E, Nakao M, Nisar NK, Nishida S, Ogawa S, Pakhlov P, Pakhlova G, Park H, Pedlar TK, Pesántez L, Petrič M, Piilonen LE, Ritter M, Rostomyan A, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schneider O, Schnell G, Schwanda C, Semmler D, Senyo K, Seon O, Seong I, Sevior ME, Shebalin V, Shibata TA, Shiu JG, Shwartz B, Simon F, Sinha R, Sohn YS, Starič M, Sumihama M, Sumisawa K, Tamponi U, Tatishvili G, Teramoto Y, Thorne F, Uchida M, Uehara S, Unno Y, Uno S, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Vinokurova A, Wagner MN, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanabe Y, Williams KM, Won E, Yamaoka J, Yashchenko S, Yook Y, Yusa Y, Zhilich V, Zhulanov V, Zupanc A. Search for the dark photon and the dark Higgs boson at belle. PHYSICAL REVIEW LETTERS 2015; 114:211801. [PMID: 26066427 DOI: 10.1103/physrevlett.114.211801] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/31/2015] [Indexed: 06/04/2023]
Abstract
The dark photon A^{'} and the dark Higgs boson h^{'} are hypothetical constituents featured in a number of recently proposed dark sector models. Assuming prompt decays of both dark particles, we search for their production in the so-called Higgstrahlung channel e^{+}e^{-}→A^{'}h^{'}, with h^{'}→A^{'}A^{'}. We investigate ten exclusive final states with A^{'}→e^{+}e^{-}, μ^{+}μ^{-}, or π^{+}π^{-} in the mass ranges 0.1 GeV/c^{2} <m_{A^{'}}<3.5 GeV/c^{2} and 0.2 GeV/c^{2} <m_{h^{'}}<10.5 GeV/c^{2}. We also investigate three inclusive final states 2(e^{+}e^{-})X, 2(μ^{+}μ^{-})X, and (e^{+}e^{-})(μ^{+}μ^{-})X, where X denotes a dark photon candidate detected via missing mass, in the mass ranges 1.1 GeV/c^{2} <m_{A^{'}}<3.5 GeV/c^{2} and 2.2 GeV/c^{2} <m_{h^{'}}<10.5 GeV/c^{2}. Using the entire 977 fb^{-1} data set collected by Belle, we observe no significant signal. We obtain individual and combined 90% credibility level upper limits on the branching fraction times the Born cross section, B×σ_{Born}, on the Born cross section σ_{Born}, and on the dark photon coupling to the dark Higgs boson times the kinetic mixing between the standard model photon and the dark photon, α_{D}×ε^{2}. These limits improve upon and cover wider mass ranges than previous experiments. The limits from the final states 3(π^{+}π^{-}) and 2(e^{+}e^{-})X are the first placed by any experiment. For α_{D} equal to 1/137, m_{h^{'}}< 8 GeV/c^{2}, and m_{A^{'}}<1 GeV/c^{2}, we exclude values of the mixing parameter ε above ∼8×10^{-4}.
Collapse
|
33
|
Pesántez L, Urquijo P, Dingfelder J, Abdesselam A, Adachi I, Adamczyk K, Aihara H, Al Said S, Arinstein K, Asner DM, Aulchenko V, Aushev T, Ayad R, Bahinipati S, Bakich AM, Bansal V, Barberio E, Bhardwaj V, Bhuyan B, Bobrov A, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi Y, Cinabro D, Dalseno J, Doležal Z, Drásal Z, Drutskoy A, Dutta D, Eidelman S, Farhat H, Fast JE, Ferber T, Frost O, Gaur V, Gabyshev N, Ganguly S, Garmash A, Getzkow D, Gillard R, Goh YM, Golob B, Haba J, Hasenbusch J, Hayashii H, He XH, Heller A, Horiguchi T, Hou WS, Huschle M, Iijima T, Inami K, Ishikawa A, Itoh R, Iwasaki Y, Jaegle I, Joffe D, Julius T, Kang KH, Kato E, Kawasaki T, Kiesling C, Kim DY, Kim JB, Kim JH, Kim KT, Kim MJ, Kim SH, Kim YJ, Ko BR, Kodyš P, Korpar S, Križan P, Krokovny P, Kronenbitter B, Kuhr T, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Li Y, Li Gioi L, Libby J, Liventsev D, Lukin P, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Moon HK, Nakano E, Nakao M, Nanut T, Natkaniec Z, Nayak M, Ng C, Nisar NK, Nishida S, Ogawa S, Okuno S, Olsen SL, Oswald C, Pakhlov P, Pakhlova G, Park CW, Park H, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Ribežl E, Ritter M, Rostomyan A, Rozanska M, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Senyo K, Seon O, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sohn YS, Sokolov A, Solovieva E, Starič M, Steder M, Sumiyoshi T, Tamponi U, Taniguchi N, Tatishvili G, Teramoto Y, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Usov Y, Van Hulse C, Vanhoefer P, Varner G, Vinokurova A, Vorobyev V, Wagner MN, Wang B, Wang CH, Wang MZ, Wang P, Watanabe Y, Williams KM, Won E, Yamaoka J, Yashchenko S, Yook Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Measurement of the Direct CP Asymmetry in B¯→X(s+dγ) Decays with a Lepton Tag. PHYSICAL REVIEW LETTERS 2015; 114:151601. [PMID: 25933306 DOI: 10.1103/physrevlett.114.151601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2015] [Indexed: 06/04/2023]
Abstract
We report the measurement of the direct CP asymmetry in the radiative B¯→X(s+dγ) decay using a data sample of (772 ± 11)×10(6) BB[over ¯] pairs collected at the ϒ(4S) resonance with the Belle detector at the KEKB asymmetric-energy e(+)e(-) collider. The CP asymmetry is measured as a function of the photon energy threshold. For Eγ*≥2.1 GeV, where Eγ* is the photon energy in the center-of-mass frame, we obtain A(CP)(B¯→X(s+dγ))=(2.2±3.9±0.9)%, consistent with the standard model prediction.
Collapse
|
34
|
Williams KM, Schulte RW, Schubert KE, Wroe AJ. Evaluation of mathematical algorithms for automatic patient alignment in radiosurgery. Technol Cancer Res Treat 2015; 14:326-33. [PMID: 25782189 DOI: 10.1177/1533034614547458] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2014] [Accepted: 05/14/2014] [Indexed: 11/15/2022] Open
Abstract
Image registration techniques based on anatomical features can serve to automate patient alignment for intracranial radiosurgery procedures in an effort to improve the accuracy and efficiency of the alignment process as well as potentially eliminate the need for implanted fiducial markers. To explore this option, four two-dimensional (2D) image registration algorithms were analyzed: the phase correlation technique, mutual information (MI) maximization, enhanced correlation coefficient (ECC) maximization, and the iterative closest point (ICP) algorithm. Digitally reconstructed radiographs from the treatment planning computed tomography scan of a human skull were used as the reference images, while orthogonal digital x-ray images taken in the treatment room were used as the captured images to be aligned. The accuracy of aligning the skull with each algorithm was compared to the alignment of the currently practiced procedure, which is based on a manual process of selecting common landmarks, including implanted fiducials and anatomical skull features. Of the four algorithms, three (phase correlation, MI maximization, and ECC maximization) demonstrated clinically adequate (ie, comparable to the standard alignment technique) translational accuracy and improvements in speed compared to the interactive, user-guided technique; however, the ICP algorithm failed to give clinically acceptable results. The results of this work suggest that a combination of different algorithms may provide the best registration results. This research serves as the initial groundwork for the translation of automated, anatomy-based 2D algorithms into a real-world system for 2D-to-2D image registration and alignment for intracranial radiosurgery. This may obviate the need for invasive implantation of fiducial markers into the skull and may improve treatment room efficiency and accuracy.
Collapse
|
35
|
Pett SL, Williams LA, Day RO, Lloyd AR, Carr AD, Clezy KR, Emery S, Kaplan E, McPhee DA, McLachlan AJ, Gelder FB, Lewin SR, Liauw W, Williams KM. A Phase I Study of the Pharmacokinetics and Safety of Passive Immunotherapy with Caprine Anti-HIV Antibodies,PEHRG214, in HIV-1--Infected Individuals. HIV CLINICAL TRIALS 2015; 5:91-8. [PMID: 15116285 DOI: 10.1310/1fln-8kfc-5heq-k19j] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
PURPOSE To establish the pharmacokinetics and safety of single-dose polyclonal caprine anti-HIV antibodies ((PE)HRG214)in HIV-1-infected individuals. DESIGN A phase 1, open-label, nonrandomized, dose-escalating study. METHOD HIV-1-infected patients with CD4+ T-cell counts of < or =200 cells/microL and plasma HIV viral load (VL)of > or =5,000 copies/mL received a single intravenous dose of HRG. Dosing began at 6,000 U/kg HRG with proposed step-wise escalation to 96,000 U/kg. RESULTS Eleven males were enrolled; median CD4+T-cell count and VL were 96 cells/microL and 126,200 copies/mL, respectively. HRG exhibited linear pharmacokinetics across the dosing range studied. The mean terminal elimination half-life (t(1/2)) was 136.6 +/- 44.6 hours (range, 52.6-198 h). Serum sickness occurred in one 48,000 U/kg HRG recipient. One 6,000 U/kg and two 24,000 U/kg HRG recipients developed a mild rash. Between baseline and day 60, VL remained unchanged (n = 6), increased by 0.67 log(10) copies/mL (n = 1), or declined by 0.34-1.55 log(10) copies/mL (n = 4). CONCLUSION Single-dose HRG exhibited linear kinetics and a long half-life. Although numbers in each dosing group were very small (n = 3), HRG was generally well tolerated in doses below 48,000 U/kg. Multiple dosing with HRG in the HIV-salvage setting may be complicated by immune-complex formation.
Collapse
|
36
|
Ghosh D, Williams KM, Graham GG, Nair P, Buscher H, Day RO. Multiple episodes of aspirin overdose in an individual patient: a case report. J Med Case Rep 2014; 8:374. [PMID: 25406385 PMCID: PMC4275751 DOI: 10.1186/1752-1947-8-374] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2014] [Accepted: 08/28/2014] [Indexed: 11/24/2022] Open
Abstract
Introduction Aspirin overdose, though now infrequently encountered, nevertheless continues to contribute to significant morbidity and mortality. The patient described in this case report intentionally ingested overdoses of aspirin on repeated occasions. The case provided an unusual and possibly one-of-a-kind opportunity to focus on the variability in the time course of plasma salicylate concentrations with current treatment modalities of aspirin overdose in an individual patient. Case presentation A 75-year-old Caucasian man who weighed 45kg and had an extensive history of various drug overdoses and stage 3 chronic kidney disease presented to a tertiary university hospital on three occasions within 2 months after successive overdoses of aspirin. During his third admission, he overdosed with aspirin, while on the ward recovering from the previous aspirin overdose. The overdoses were categorized as “potentially lethal” on two occasions and as “serious” in the other two, based on the alleged dose of aspirin ingested (over 500mg/kg in the first two overdoses, and 320mg/kg and 498mg/kg in the other two, respectively). However, as assessed by the observed salicylate concentrations, the ingestions would more appropriately have been categorized as being of “moderate” severity for the first and second overdose and “mild” severity for each of the others. This categorization was more consistent with the clinical severity of his admissions. A single dose of activated charcoal was administered only after the second overdose. On each occasion, he was given intravenous fluid with the aim of achieving euvolemia. Urinary alkalization was not attempted during the first admission, which was associated with the longest apparent elimination half-life of salicylate (30 hours). A plasma potassium concentration of approximately 4mmol/L appeared to be needed for adequate urinary alkalization. Conclusion In a patient with impaired renal function, intravenous fluid and urinary alkalization are the mainstays of treatment of aspirin overdose. Correction of hypokalemia is recommended. Repeated doses of charcoal may be a worthwhile intervention when there is no risk of aspiration. Our experience in this case also revealed considerable unexplained variation in management despite the availability of guidelines. It is, therefore, important to monitor the implementation of available guidelines.
Collapse
|
37
|
He XH, Shen CP, Yuan CZ, Ban Y, Abdesselam A, Adachi I, Aihara H, Asner DM, Aulchenko V, Aushev T, Ayad R, Bahinipati S, Bakich AM, Bansal V, Bhuyan B, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Cervenkov D, Chang P, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Danilov M, Doležal Z, Drásal Z, Drutskoy A, Eidelman S, Farhat H, Fast JE, Ferber T, Gaur V, Gabyshev N, Ganguly S, Garmash A, Gillard R, Glattauer R, Goh YM, Grzymkowska O, Haba J, Hayasaka K, Hayashii H, Hou WS, Iijima T, Ishikawa A, Itoh R, Iwasaki Y, Jaegle I, Joo KK, Julius T, Kato E, Kawasaki T, Kim DY, Kim MJ, Kim YJ, Kinoshita K, Ko BR, Kodyš P, Korpar S, Križan P, Krokovny P, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Li Y, Libby J, Liventsev D, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Mussa R, Nakano E, Nakao M, Nakazawa H, Nanut T, Natkaniec Z, Nedelkovska E, Nisar NK, Nishida S, Ogawa S, Okuno S, Pakhlov P, Pakhlova G, Park H, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Ritter M, Rostomyan A, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schneider O, Schnell G, Schwanda C, Semmler D, Senyo K, Sevior ME, Shebalin V, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sohn YS, Sokolov A, Solovieva E, Starič M, Steder M, Sumisawa K, Sumiyoshi T, Tamponi U, Tanida K, Tatishvili G, Teramoto Y, Thorne F, Trabelsi K, Uchida M, Uehara S, Uglov T, Unno Y, Uno S, Urquijo P, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Vinokurova A, Vorobyev V, Wagner MN, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanabe Y, Wehle S, Williams KM, Won E, Yamaoka J, Yashchenko S, Yook Y, Yusa Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Observation of e+e- → π+π-π(0)(χbJ) and Search for X(b) → ωϒ(1S) at sqrt[s] = 10.867 GeV. PHYSICAL REVIEW LETTERS 2014; 113:142001. [PMID: 25325633 DOI: 10.1103/physrevlett.113.142001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/03/2014] [Indexed: 06/04/2023]
Abstract
The e(+)e(-) → π(+)π(-)π(0)χ(bJ) (J = 0,1,2) processes are studied using a 118 fb(-1) data sample acquired with the Belle detector at a center-of-mass energy of 10.867 GeV. Unambiguous π(+)π(-)π(0)χ(bJ) (J = 1,2), ωχ(b1) signals are observed, and indication for ωχ(b2) is seen, both for the first time, and the corresponding cross section measurements are presented. No significant π(+)π(-)π(0)χ(b0) or ωχ(b0) signals are observed, and 90% confidence level upper limits on the cross sections for these two processes are obtained. In the π(+)π(-)π(0) invariant mass spectrum, significant non-ω signals are also observed. We search for the X(3872)-like state (named X(b)) decaying into ωϒ(1S); no significant signal is observed with a mass between 10.55 and 10.65 GeV/c(2).
Collapse
|
38
|
Chung WH, Chang WC, Stocker SL, Juo CG, Graham GG, Lee MHH, Williams KM, Tian YC, Juan KC, Jan Wu YJ, Yang CH, Chang CJ, Lin YJ, Day RO, Hung SI. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Ann Rheum Dis 2014; 74:2157-64. [PMID: 25115449 DOI: 10.1136/annrheumdis-2014-205577] [Citation(s) in RCA: 131] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2014] [Accepted: 07/26/2014] [Indexed: 12/11/2022]
Abstract
OBJECTIVE Allopurinol, an antihyperuricaemic agent, is one of the common causes of life-threatening severe cutaneous adverse reactions (SCAR), including drug rash with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN). The prognostic factors for allopurinol-related SCAR remain unclear. This study aimed to investigate the relationship of dosing, renal function, plasma levels of oxypurinol and granulysin (a cytotoxic protein of SJS/TEN), the disease severity and mortality in allopurinol-SCAR. METHODS We prospectively enrolled 48 patients with allopurinol-SCAR (26 SJS/TEN and 22 DRESS) and 138 allopurinol-tolerant controls from 2007 to 2012. The human leucocyte antigen (HLA)-B*58:01 status, plasma concentrations of oxypurinol and granulysin were determined. RESULTS In this cohort, HLA-B*58:01 was strongly associated with allopurinol-SCAR (p<0.001, OR (95% CI) 109 (25 to 481)); however, the initial/maintenance dosages showed no relationship with the disease. Poor renal function was significantly associated with the delayed clearance of plasma oxypurinol, and increased the risk of allopurinol-SCAR (p<0.001, OR (95% CI) 8.0 (3.9 to 17)). Sustained high levels of oxypurinol after allopurinol withdrawal correlated with the poor prognosis of allopurinol-SCAR. In particular, the increased plasma levels of oxypurinol and granulysin linked to the high mortality of allopurinol-SJS/TEN (p<0.01), and strongly associated with prolonged cutaneous reactions in allopurinol-DRESS (p<0.05). CONCLUSIONS Impaired renal function and increased plasma levels of oxypurinol and granulysin correlated with the poor prognosis of allopurinol-SCAR. Allopurinol prescription is suggested to be avoided in subjects with renal insufficiency and HLA-B*58:01 carriers. An early intervention to increase the clearance of plasma oxypurinol may improve the prognosis of allopurinol-SCAR.
Collapse
|
39
|
Zupanc A, Bartel C, Gabyshev N, Adachi I, Aihara H, Asner DM, Aulchenko V, Aushev T, Bakich AM, Bala A, Belous K, Bhuyan B, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chang MC, Chekelian V, Cheon BG, Chilikin K, Chistov R, Cho IS, Cho K, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Danilov M, Doležal Z, Drásal Z, Dutta D, Dutta K, Eidelman S, Epifanov D, Farhat H, Fast JE, Feindt M, Ferber T, Gaur V, Ganguly S, Garmash A, Gillard R, Glattauer R, Goh YM, Golob B, Haba J, Hayasaka K, Hayashii H, He XH, Hoshi Y, Hou WS, Huschle M, Hyun HJ, Iijima T, Ishikawa A, Itoh R, Iwasaki Y, Iwashita T, Jaegle I, Julius T, Kang JH, Kato E, Kato Y, Kawasaki T, Kichimi H, Kim DY, Kim HJ, Kim JB, Kim JH, Kim MJ, Kim YJ, Kinoshita K, Klucar J, Ko BR, Kodyš P, Korpar S, Križan P, Krokovny P, Kronenbitter B, Kuhr T, Kumita T, Kuzmin A, Kwon YJ, Lee SH, Li J, Li Y, Libby J, Liu C, Liu Y, Liu ZQ, Liventsev D, MacNaughton J, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Mussa R, Nakano E, Nakao M, Nakazawa H, Natkaniec Z, Nayak M, Nedelkovska E, Niiyama M, Nisar NK, Nishida S, Nitoh O, Ogawa S, Olsen SL, Ostrowicz W, Pakhlov P, Pakhlova G, Park CW, Park H, Park HK, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Ritter M, Röhrken M, Rostomyan A, Ryu S, Sahoo H, Saito T, Sakai Y, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Semmler D, Senyo K, Seon O, Sevior ME, Shapkin M, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sohn YS, Sokolov A, Solovieva E, Stanič S, Starič M, Steder M, Sumiyoshi T, Tamponi U, Tanida K, Tatishvili G, Teramoto Y, Trabelsi K, Uchida M, Uehara S, Unno Y, Uno S, Urquijo P, Usov Y, Van Hulse C, Vanhoefer P, Varner G, Varvell KE, Vinokurova A, Vorobyev V, Wagner MN, Wang CH, Wang P, Wang XL, Watanabe M, Watanabe Y, Williams KM, Won E, Yamamoto H, Yamashita Y, Yashchenko S, Yook Y, Zhang ZP, Zhilich V, Zhulanov V. Measurement of the branching fraction B(Λc+ → pK-π+). PHYSICAL REVIEW LETTERS 2014; 113:042002. [PMID: 25105609 DOI: 10.1103/physrevlett.113.042002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2013] [Indexed: 06/03/2023]
Abstract
We present the first model-independent measurement of the absolute branching fraction of the Λ(c)(+) → pK(-)π(+) decay using a data sample of 978 fb(-1) collected with the Belle detector at the KEKB asymmetric-energy e(+)e(-) collider. The number of Λ(c)(+) baryons is determined by reconstructing the recoiling D((*)-) pπ(+) system in events of the type e(+)e(-) → D((*)-) pπ(+)Λ(c)(+). The branching fraction is measured to be B(Λ(c)(+) → pK(-)π(+)) = (6.84 ± 0.24(-0.27)(+0.21))%, where the first and second uncertainties are statistical and systematic, respectively.
Collapse
|
40
|
Graham GG, Kannangara DRW, Stocker SL, Portek I, Pile KD, Indraratna PL, Datta I, Williams KM, Day RO. Understanding the dose-response relationship of allopurinol: predicting the optimal dosage. Br J Clin Pharmacol 2014; 76:932-8. [PMID: 23590252 DOI: 10.1111/bcp.12126] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2012] [Accepted: 03/18/2013] [Indexed: 11/27/2022] Open
Abstract
AIMS The aim of the study was to identify and quantify factors that control the plasma concentrations of urate during allopurinol treatment and to predict optimal doses of allopurinol. METHODS Plasma concentrations of urate and creatinine (112 samples, 46 patients) before and during treatment with various doses of allopurinol (50-600 mg daily) were monitored. Non-linear and multiple linear regression equations were used to examine the relationships between allopurinol dose (D), creatinine clearance (CLcr) and plasma concentrations of urate before (UP) and during treatment with allopurinol (UT). RESULTS Plasma concentrations of urate achieved during allopurinol therapy were dependent on the daily dose of allopurinol and the plasma concentration of urate pre-treatment. The non-linear equation: UT = (1 - D/(ID50 + D)) × (UP - UR) + UR , fitted the data well (r(2) = 0.74, P < 0.0001). The parameters and their best fit values were: daily dose of allopurinol reducing the inhibitable plasma urate by 50% (ID50 = 226 mg, 95% CI 167, 303 mg), apparent resistant plasma urate (UR = 0.20 mmol l(-1), 95 % CI 0.14, 0.25 mmol l(-1)). Incorporation of CLcr did not significantly improve the fit (P = 0.09). CONCLUSIONS A high baseline plasma urate concentration requires a high dose of allopurinol to reduce plasma urate below recommended concentrations. This dose is dependent on only the pre-treatment plasma urate concentration and is not influenced by CLcr .
Collapse
|
41
|
Wong C, Kumar SS, Graham GG, Begg EJ, Chin PKL, Brett J, Ray JE, Marriott DJE, Williams KM, Day RO. Comparing dose prediction software used to manage gentamicin dosing. Intern Med J 2014; 43:519-25. [PMID: 23279297 DOI: 10.1111/imj.12067] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2012] [Accepted: 11/21/2012] [Indexed: 11/28/2022]
Abstract
BACKGROUND Current Australian guidelines recommend initiating directed therapy of gentamicin if administration exceeds 48 h. Directed doses of gentamicin require the monitoring of plasma concentrations of gentamicin to determine the 24-h area under the time course of plasma gentamicin concentrations (AUC) and a dosage prediction program, for example TCIWorks or Aladdin. However, doses calculated by such programs have not been compared with an established program. AIM To compare the directed dosage of gentamicin calculated by TCIWorks, Aladdin and an Excel-based program, with an established program, Abbottbase. METHODS Peak and trough plasma concentrations after the first and second administered doses of gentamicin were available from three patient groups (n = 20-23) with varying creatinine clearances (<40, 40-80, >80 mL/min). The directed dose needed to produce 24-h AUC values of 80 mg.h/L was calculated using each program. RESULTS There was a strong correlation between the directed doses predicted by each of the three programs compared with Abbottbase, following the first administered dose (r(2) > 0.97, P < 0.0001). The mean ratio (90% confidence intervals) of these directed doses of the gentamicin were: TCIWorks/Abbottbase 106% (105-107%), Aladdin/Abbottbase 102% (101-103%) and Excel/Abbottbase 108% (106-109%). The correlations and dose ratios were also similar when comparisons were made following the second administered dose. For each of the three renal function groups, all programs yielded similar directed doses. CONCLUSIONS The four programs used in the calculation of directed doses of gentamicin yielded similar results. Any would be suitable for use in clinical practice.
Collapse
|
42
|
Savory LA, Griffin SJ, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Simmons RK. Changes in diet, cardiovascular risk factors and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort. Diabet Med 2014; 31:148-55. [PMID: 24102972 PMCID: PMC4208684 DOI: 10.1111/dme.12316] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/21/2013] [Revised: 08/05/2013] [Accepted: 09/04/2013] [Indexed: 02/03/2023]
Abstract
AIMS To describe change in self-reported diet and plasma vitamin C, and to examine associations between change in diet and cardiovascular disease risk factors and modelled 10-year cardiovascular disease risk in the year following diagnosis of Type 2 diabetes. METHODS Eight hundred and sixty-seven individuals with screen-detected diabetes underwent assessment of self-reported diet, plasma vitamin C, cardiovascular disease risk factors and modelled cardiovascular disease risk at baseline and 1 year (n = 736) in the ADDITION-Cambridge trial. Multivariable linear regression was used to quantify the association between change in diet and cardiovascular disease risk at 1 year, adjusting for change in physical activity and cardio-protective medication. RESULTS Participants reported significant reductions in energy, fat and sodium intake, and increases in fruit, vegetable and fibre intake over 1 year. The reduction in energy was equivalent to an average-sized chocolate bar; the increase in fruit was equal to one plum per day. There was a small increase in plasma vitamin C levels. Increases in fruit intake and plasma vitamin C were associated with small reductions in anthropometric and metabolic risk factors. Increased vegetable intake was associated with an increase in BMI and waist circumference. Reductions in fat, energy and sodium intake were associated with reduction in HbA1c , waist circumference and total cholesterol/modelled cardiovascular disease risk, respectively. CONCLUSIONS Improvements in dietary behaviour in this screen-detected population were associated with small reductions in cardiovascular disease risk, independently of change in cardio-protective medication and physical activity. Dietary change may have a role to play in the reduction of cardiovascular disease risk following diagnosis of diabetes.
Collapse
|
43
|
Belous K, Shapkin M, Sokolov A, Adachi I, Aihara H, Asner DM, Aulchenko V, Bakich AM, Bala A, Bhuyan B, Bobrov A, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi Y, Cinabro D, Dalseno J, Doležal Z, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Gaur V, Ganguly S, Garmash A, Gillard R, Goh YM, Golob B, Haba J, Hara T, Hayasaka K, Hayashii H, Hoshi Y, Hou WS, Iijima T, Inami K, Ishikawa A, Itoh R, Iwashita T, Jaegle I, Julius T, Kato E, Kichimi H, Kiesling C, Kim DY, Kim HJ, Kim JB, Kim MJ, Kim YJ, Kinoshita K, Ko BR, Kodyš P, Korpar S, Križan P, Krokovny P, Kuhr T, Kuzmin A, Kwon YJ, Lange JS, Lee SH, Libby J, Liventsev D, Lukin P, Matvienko D, Miyata H, Mizuk R, Mohanty GB, Mori T, Mussa R, Nagasaka Y, Nakano E, Nakao M, Nayak M, Nedelkovska E, Ng C, Nisar NK, Nishida S, Nitoh O, Ogawa S, Okuno S, Olsen SL, Ostrowicz W, Pakhlova G, Park CW, Park H, Park HK, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Ritter M, Röhrken M, Rostomyan A, Ryu S, Sahoo H, Saito T, Sakai Y, Sandilya S, Santel D, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Semmler D, Senyo K, Seon O, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sohn YS, Stanič S, Starič M, Steder M, Sumiyoshi T, Tamponi U, Tatishvili G, Teramoto Y, Trabelsi K, Tsuboyama T, Uchida M, Uehara S, Uglov T, Unno Y, Uno S, Usov Y, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Varvell KE, Vinokurova A, Vorobyev V, Wagner MN, Wang CH, Wang P, Watanabe M, Watanabe Y, Williams KM, Won E, Yamaoka J, Yamashita Y, Yashchenko S, Yook Y, Yuan CZ, Zhang ZP, Zhilich V, Zupanc A. Measurement of the τ-lepton lifetime at Belle. PHYSICAL REVIEW LETTERS 2014; 112:031801. [PMID: 24484129 DOI: 10.1103/physrevlett.112.031801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/01/2013] [Indexed: 06/03/2023]
Abstract
The lifetime of the τ lepton is measured using the process e+ e- → τ+ τ- , where both τ leptons decay to 3πν(τ). The result for the mean lifetime, based on 711 fb(-1) of data collected with the Belle detector at the ϒ(4S) resonance and 60 MeV below, is τ=(290.17±0.53(stat)±0.33(syst))×10(-15) s. The first measurement of the lifetime difference between τ+ and τ- is performed. The upper limit on the relative lifetime difference between positive and negative τ leptons is |Δτ|/τ<7.0×10(-3) at 90% C.L.
Collapse
|
44
|
Duong JK, Kumar SS, Kirkpatrick CM, Greenup LC, Arora M, Lee TC, Timmins P, Graham GG, Furlong TJ, Greenfield JR, Williams KM, Day RO. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet 2013; 52:373-84. [PMID: 23475568 DOI: 10.1007/s40262-013-0046-9] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND AND OBJECTIVE Metformin is contraindicated in patients with renal impairment; however, there is poor adherence to current dosing guidelines. In addition, the pharmacokinetics of metformin in patients with significant renal impairment are not well described. The aims of this study were to investigate factors influencing the pharmacokinetic variability, including variant transporters, between healthy subjects and patients with type 2 diabetes mellitus (T2DM) and to simulate doses of metformin at varying stages of renal function. METHODS Plasma concentrations of metformin were pooled from three studies: patients with T2DM (study A; n = 120), healthy Caucasian subjects (study B; n = 16) and healthy Malaysian subjects (study C; n = 169). A population pharmacokinetic model of metformin was developed using NONMEM(®) version VI for both the immediate-release (IR) formulation and the extended-release (XR) formulation of metformin. Total body weight (TBW), lean body weight (LBW), creatinine clearance (CLCR; estimated using TBW and LBW) and 57 single-nucleotide polymorphisms (SNPs) of metformin transporters (OCT1, OCT2, OCT3, MATE1 and PMAT) were investigated as potential covariates. A nonparametric bootstrap (n = 1,000) was used to evaluate the final model. This model was used to simulate 1,000 concentration-time profiles for doses of metformin at each stage of renal impairment to ensure metformin concentrations do not exceed 5 mg/l, the proposed upper limit. RESULTS Creatinine clearance and TBW were clinically and statistically significant covariates with the apparent clearance and volume of distribution of metformin, respectively. None of the 57 SNPs in transporters of metformin were significant covariates. In contrast to previous studies, there was no effect on the pharmacokinetics of metformin in patients carrying the reduced function OCT1 allele (R61C, G401S, 420del or G465R). Dosing simulations revealed that the maximum daily doses in relation to creatinine clearance to prescribe to patients are 500 mg (15 ml/min), 1,000 mg (30 ml/min), 2,000 mg (60 ml/min) and 3,000 mg (120 ml/min), for both the IR and XR formulations. CONCLUSION The population model enabled doses of metformin to be simulated for each stage of renal function, to ensure the concentrations of metformin do not exceed 5 mg/l. However, the plasma concentrations of metformin at these dosage levels are still quite variable and monitoring metformin concentrations may be of value in individualising dosage. This study provides confirmatory data that metformin can be used, with appropriate dosage adjustment, in patients with renal impairment.
Collapse
|
45
|
Sandilya S, Trabelsi K, Mohanty GB, Adachi I, Aihara H, Asner DM, Aushev T, Aziz T, Bakich AM, Bala A, Bhardwaj V, Bhuyan B, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Chen P, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Dingfelder J, Doležal Z, Drutskoy A, Dutta D, Eidelman S, Farhat H, Fast JE, Feindt M, Ferber T, Frey A, Gaur V, Gabyshev N, Ganguly S, Gillard R, Goh YM, Golob B, Haba J, Hara T, Hayasaka K, Hayashii H, Hoshi Y, Hou WS, Hsiung YB, Hyun HJ, Iijima T, Ishikawa A, Itoh R, Iwasaki Y, Julius T, Kah DH, Kang JH, Kato E, Kawai H, Kawasaki T, Kiesling C, Kim DY, Kim HO, Kim JB, Kim JH, Kim YJ, Klucar J, Ko BR, Kodyš P, Korpar S, Križan P, Krokovny P, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Lee SH, Li J, Li Y, Libby J, Liu ZQ, Liventsev D, Lukin P, MacNaughton J, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Moll A, Muramatsu N, Mussa R, Nagasaka Y, Nakao M, Nayak M, Ng C, Nisar NK, Nishida S, Nitoh O, Ogawa S, Okuno S, Oswald C, Pakhlova G, Park CW, Park H, Park HK, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Ritter M, Röhrken M, Rostomyan A, Ryu S, Sahoo H, Saito T, Sakai K, Sakai Y, Santelj L, Sanuki T, Sato Y, Savinov V, Schneider O, Schnell G, Semmler D, Senyo K, Sevior ME, Shapkin M, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sohn YS, Sokolov A, Solovieva E, Stanič S, Starič M, Steder M, Sumiyoshi T, Tamponi U, Tanida K, Tatishvili G, Teramoto Y, Tsuboyama T, Uchida M, Uehara S, Uglov T, Unno Y, Uno S, Urquijo P, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Vorobyev V, Wagner MN, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe M, Watanabe Y, Wiechczynski J, Williams KM, Won E, Yabsley BD, Yamaoka J, Yamashita Y, Yashchenko S, Yuan CZ, Yusa Y, Zhang CC, Zhang ZP, Zhilich V, Zupanc A. Search for bottomonium states in exclusive radiative Υ(2S) decays. PHYSICAL REVIEW LETTERS 2013; 111:112001. [PMID: 24074074 DOI: 10.1103/physrevlett.111.112001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/27/2013] [Indexed: 06/02/2023]
Abstract
We search for bottomonium states in Υ(2S) → (bb)γ decays with an integrated luminosity of 24.7 fb(-1) recorded at the Υ(2S) resonance with the Belle detector at KEK, containing (157.8±3.6)×10(6) Υ(2S) events. The (bb) system is reconstructed in 26 exclusive hadronic final states composed of charged pions, kaons, protons, and K(S)(0) mesons. We find no evidence for the state recently observed around 9975 MeV (X(bb)) in an analysis based on a data sample of 9.3×10(6) Υ(2S) events collected with the CLEO III detector. We set a 90% confidence level upper limit on the branching fraction B[Υ(2S) → X(bb)γ] × ∑(i)B[X(bb) → h(i)] < 4.9×10(-6), summed over the exclusive hadronic final states employed in our analysis. This result is an order of magnitude smaller than the measurement reported with CLEO data. We also set an upper limit for the ηb(1S) state of B[Υ(2S) → ηb(1S)γ] × ∑(i)B[ηb(1S) → h(i)] < 3.7×10(-6).
Collapse
|
46
|
Leitgab M, Seidl R, Grosse Perdekamp M, Vossen A, Adachi I, Aihara H, Asner DM, Aulchenko V, Aushev T, Bakich AM, Bhuyan B, Bondar A, Bozek A, Bračko M, Brodzicka J, Browder TE, Chekelian V, Chen A, Chen P, Cheon BG, Chilikin K, Cho K, Chobanova V, Choi Y, Cinabro D, Dalseno J, Drásal Z, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Gaur V, Gabyshev N, Gillard R, Giordano F, Goh YM, Golob B, Haba J, Hayasaka K, Hayashii H, Hoshi Y, Hou WS, Hsiung YB, Hyun HJ, Iijima T, Ishikawa A, Itoh R, Jacobs WW, Julius T, Kang JH, Kapusta P, Kato E, Kawasaki T, Kim HJ, Kim HO, Kim JB, Kim JH, Kim MJ, Klucar J, Ko BR, Kodyš P, Kouzes RT, Križan P, Krokovny P, Kumar R, Kumita T, Kwon YJ, Lange JS, Lee SH, Li Y, Liu ZQ, Liventsev D, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Moll A, Muramatsu N, Nakano E, Nakao M, Natkaniec Z, Nayak M, Nedelkovska E, Ng C, Nisar NK, Nitoh O, Ogawa A, Ogawa S, Ohshima T, Okuno S, Olsen SL, Oswald C, Pakhlov P, Park H, Park HK, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Röhrken M, Sahoo H, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Schneider O, Schnell G, Schwanda C, Senyo K, Seon O, Sevior ME, Shapkin M, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Smerkol P, Sohn YS, Sokolov A, Solovieva E, Starič M, Sumihama M, Sumiyoshi T, Tatishvili G, Teramoto Y, Tsuboyama T, Uchida M, Uglov T, Unno Y, Uno S, Usov Y, Van Hulse C, Varner G, Vorobyev V, Wagner MN, Wang CH, Wang J, Wang MZ, Wang P, Watanabe M, Watanabe Y, Williams KM, Won E, Yamashita Y, Zhilich V, Zhulanov V. Precision measurement of charged pion and kaon differential cross sections in e+ e- annihilation at sqrt[s]=10.52 GeV. PHYSICAL REVIEW LETTERS 2013; 111:062002. [PMID: 23971562 DOI: 10.1103/physrevlett.111.062002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/25/2013] [Indexed: 06/02/2023]
Abstract
Measurements of inclusive differential cross sections for charged pion and kaon production in e+ e- annihilation have been carried out at a center-of-mass energy of sqrt[s]=10.52 GeV. The measurements were performed with the Belle detector at the KEKB e+ e- collider using a data sample containing 113×10(6) e+ e- → qq events, where q={u,d,s,c}. We present charge-integrated differential cross sections dσ(h±)/dz for h±={π±,K±} as a function of the relative hadron energy z=2E(h)/sqrt[s] from 0.2 to 0.98. The combined statistical and systematic uncertainties for π± (K±) are 4% (4%) at z∼0.6 and 15% (24%) at z∼0.9. The cross sections are the first measurements of the z dependence of pion and kaon production for z>0.7 as well as the first precision cross section measurements at a center-of-mass energy far below the Z0 resonance used by the experiments at LEP and SLC.
Collapse
|
47
|
Ramasamy SN, Korb-Wells CS, Kannangara DRW, Smith MWH, Wang N, Roberts DM, Graham GG, Williams KM, Day RO. Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012. Drug Saf 2013; 36:953-80. [DOI: 10.1007/s40264-013-0084-0] [Citation(s) in RCA: 128] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
48
|
Kim BH, Olsen SL, Adachi I, Aihara H, Asner DM, Aulchenko V, Bay A, Belous K, Bhuyan B, Bonvicini G, Bozek A, Bračko M, Browder TE, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Cho IS, Cho K, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Doležal Z, Eidelman S, Epifanov D, Esen S, Farhat H, Fast JE, Gaur V, Ganguly S, Gillard R, Goh YM, Hayasaka K, Hayashii H, Hoshi Y, Hou WS, Hsiung YB, Hyun HJ, Inami K, Ishikawa A, Itoh R, Iwasaki Y, Julius T, Kah DH, Kang JH, Kapusta P, Kato E, Kichimi H, Kim HJ, Kim HO, Kim JH, Kim KT, Kim MJ, Kim SK, Kim YJ, Kinoshita K, Klucar J, Ko BR, Kodyš P, Korpar S, Kouzes RT, Križan P, Krokovny P, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Lee SH, Li J, Li X, Li Y, Libby J, Liventsev D, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Muramatsu N, Mussa R, Nakano E, Nakao M, Nedelkovska E, Ng C, Nisar NK, Nishida S, Nishimura K, Ohshima T, Okuno S, Pakhlov P, Pakhlova G, Park H, Park HK, Peters M, Petrič M, Piilonen LE, Ritter M, Ryu S, Sahoo H, Sakai Y, Sandilya S, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Semmler D, Senyo K, Seon O, Sevior ME, Shapkin M, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Smerkol P, Sohn YS, Sokolov A, Solovieva E, Stanič S, Starič M, Sumihama M, Sumiyoshi T, Tamponi U, Tanida K, Tatishvili G, Teramoto Y, Trabelsi K, Uchida M, Uehara S, Uglov T, Unno Y, Uno S, Usov Y, Van Hulse C, Varner G, Vorobyev V, Wagner MN, Wang CH, Wang P, Watanabe Y, Williams KM, Won E, Yamashita Y, Zhilich V, Zupanc A. Search for an H-dibaryon with a mass near 2mΛ in Υ(1S) and Υ(2S) decays. PHYSICAL REVIEW LETTERS 2013; 110:222002. [PMID: 23767713 DOI: 10.1103/physrevlett.110.222002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/16/2013] [Revised: 05/03/2013] [Indexed: 06/02/2023]
Abstract
We report the results of a high-statistics search for H dibaryon production in inclusive Υ(1S) and Υ(2S) decays. No indication of an H dibaryon with a mass near the M(H)=2m(Λ) threshold is seen in either the H→Λpπ(-) or ΛΛ decay channels and 90% confidence level branching-fraction upper limits are set that are between one and two orders of magnitude below the measured branching fractions for inclusive Υ(1S) and Υ(2S) decays to antideuterons. Since Υ(1S,2S) decays produce flavor-SU(3)-symmetric final states, these results put stringent constraints on H dibaryon properties. The results are based on analyses of 102 million Υ(1S) and 158 million Υ(2S) events collected with the Belle detector at the KEKB e(+)e(-) collider.
Collapse
|
49
|
Hara K, Horii Y, Iijima T, Adachi I, Aihara H, Asner DM, Aushev T, Aziz T, Bakich AM, Barrett M, Bhardwaj V, Bhuyan B, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Chekelian V, Chen A, Chen P, Cheon BG, Chilikin K, Cho IS, Cho K, Choi Y, Cinabro D, Dalseno J, Dingfelder J, Doležal Z, Drásal Z, Drutskoy A, Dutta D, Eidelman S, Epifanov D, Esen S, Farhat H, Frey A, Gaur V, Gabyshev N, Ganguly S, Gillard R, Goh YM, Golob B, Haba J, Hara T, Hayasaka K, Hayashii H, Higuchi T, Hoshi Y, Inami K, Ishikawa A, Itoh R, Iwasaki Y, Iwashita T, Julius T, Kang JH, Kawasaki T, Kiesling C, Kim HO, Kim JB, Kim JH, Kim KT, Kim MJ, Kim YJ, Kinoshita K, Klucar J, Ko BR, Kodyš P, Korpar S, Kouzes RT, Križan P, Krokovny P, Kronenbitter B, Kuhr T, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Lee SH, Li J, Li Y, Libby J, Liu C, Liu Y, Liu ZQ, Liventsev D, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Mori T, Muramatsu N, Nakano E, Nakao M, Nakazawa H, Natkaniec Z, Nayak M, Ng C, Nisar NK, Nishida S, Nishimura K, Nitoh O, Nozaki T, Ohshima T, Okuno S, Olsen SL, Oswald C, Ozaki H, Pakhlov P, Pakhlova G, Park CW, Park HK, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Prim M, Röhrken M, Ryu S, Sahoo H, Sakai K, Sakai Y, Sandilya S, Santel D, Sanuki T, Sato Y, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Senyo K, Seon O, Sevior ME, Shapkin M, Shen CP, Shibata TA, Shiu JG, Shwartz B, Sibidanov A, Simon F, Smerkol P, Sohn YS, Sokolov A, Solovieva E, Starič M, Sumihama M, Sumiyoshi T, Tatishvili G, Teramoto Y, Trabelsi K, Tsuboyama T, Uchida M, Uehara S, Unno Y, Uno S, Urquijo P, Ushiroda Y, Usov Y, Van Hulse C, Vanhoefer P, Varner G, Varvell KE, Vorobyev V, Wagner MN, Wang CH, Wang MZ, Wang P, Watanabe M, Watanabe Y, Williams KM, Won E, Yabsley BD, Yamamoto H, Yamashita Y, Yusa Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Evidence for B- → τ- ν(τ) with a hadronic tagging method using the full data sample of Belle. PHYSICAL REVIEW LETTERS 2013; 110:131801. [PMID: 23581309 DOI: 10.1103/physrevlett.110.131801] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2012] [Indexed: 06/02/2023]
Abstract
We measure the branching fraction of B- → τ- ν(τ) using the full Υ(4S) data sample containing 772×10(6) BB pairs collected with the Belle detector at the KEKB asymmetric-energy e+ e- collider. Events with BB pairs are tagged by reconstructing one of the B mesons decaying into hadronic final states, and B- → τ- ν(τ) candidates are detected in the recoil. We find evidence for B- → τ- ν(τ) with a significance of 3.0 standard deviations including systematic errors and measure a branching fraction B(B- → τ- ν(τ))=[0.72(-0.25)(+0.27)(stat)±0.11(syst)]×10(-4).
Collapse
|
50
|
Barakat A, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ, Simmons RK. Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort. Diabet Med 2013; 30:233-8. [PMID: 22913463 PMCID: PMC3814417 DOI: 10.1111/j.1464-5491.2012.03765.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
AIMS To describe change in physical activity over 1 year and associations with change in cardiovascular disease risk factors in a population with screen-detected Type 2 diabetes. METHODS Eight hundred and sixty-seven individuals with screen-detected diabetes underwent measurement of self-reported physical activity, cardiovascular disease risk factors and modelled cardiovascular disease risk at baseline and 1 year (n = 736) in the ADDITION-Cambridge trial. Multiple linear regression was used to quantify the association between change in different physical activity domains and cardiovascular disease risk factors at 1 year. RESULTS There was no change in self-reported physical activity over 12 months. Even relatively large changes in physical activity were associated with relatively small changes in cardiovascular disease risk factors after allowing for changes in self-reported medication and diet. For every 30 metabolic equivalent-h increase in recreational activity (equivalent to 10 h/brisk walking/week), there was an average reduction of 0.1% in HbA(1c) in men (95% CI -0.15 to -0.01, P = 0.021) and an average reduction of 2 mmHg in systolic blood pressure in women (95% CI -4.0 to -0.05, P = 0.045). CONCLUSIONS Few associations were observed between change in different physical activity domains and cardiovascular disease risk factors in this trial cohort. Cardiovascular disease risk reduction appeared to be driven largely by factors other than changes in self-reported physical activity in the first year following diagnosis.
Collapse
|